New Ebola Vaccine May Be Too Good to Be True (The Conversation)

Lahey, however, questions the success of the vaccine. There are three reasons, he says, why “we cannot know if the vaccine really worked, or how well. Those reasons are the lack of placebo comparison, the way the investigators diagnosed vaccine failure, and the possibility of statistical flukes.”

Lahey is an associate professor of medicine and of microbiology and immunology at .

, published 8/11/15 by The Conversation.